5 Most Valuable Drug Companies in 2024

In this article, we are going to look at the 5 most valuable drug companies in 2024. If you want to read more about the largest drug companies in the world and check out our detailed analysis of the pharmaceutical drugs market, you can go to 30 Most Valuable Drug Companies in 2024.

5. AbbVie Inc. (NYSE:ABBV)

Market Capitalization: $308.59 Billion

AbbVie Inc. (NYSE:ABBV) is an American pharmaceutical company that ranks among the top 5 most valuable drug companies in 2024. As one of the world’s largest biomedical companies, it serves more than 175 countries around the world through its products. AbbVie Inc. (NYSE:ABBV) has a market capitalization of $308.59 billion as of February 8, 2024.

4. Merck & Co. Inc. (NYSE:MRK)

Market Capitalization: $320.83 Billion

Merck & Co. Inc. (NYSE:MRK) is an American multinational pharmaceutical company. The company develops and produces medicines, vaccines, biologic therapies, and animal health products. As of February 8, 2024, Merck & Co. Inc. (NYSE:MRK) has a market capitalization of $320.83 billion. It is one of the most valuable drug companies in 2024.

3. Johnson & Johnson (NYSE:JNJ)

Market Capitalization: $376.49 Billion

Johnson & Johnson is an American multinational pharmaceutical company that ranks among the top 3 on our list of most valuable drug companies in 2024. It is also a medical technologies company that innovates at the intersection of biology and technology. Johnson & Johnson (NYSE:JNJ) has a market capitalization of $376.49 billion as of February 8, 2024.

2. Novo Nordisk A/S (NYSE:NVO)

Market Capitalization: $527.53 Billion

Novo Nordisk A/S (NYSE:NVO) is a Danish multinational pharmaceutical company that ranks second on our list of most valuable drug companies in 2024. It develops, produces, and markets pharmaceutical products with a focus on diabetes care, insulin delivery systems, and other diabetes products. As of February 8, 2024, Novo Nordisk A/S (NYSE:NVO) has a market capitalization of $527.53 billion.

1. Eli Lilly and Company (NYSE:LLY)

Market Capitalization: $698.37 Billion

Eli Lilly and Company (NYSE:LLY) is an American pharmaceutical company that tops our list of the 30 most valuable drug companies in 2024. It has a market capitalization of $698.37 billion as of February 8, 2024. With manufacturing plants located in 7 different countries, Eli Lilly and Company’s (NYSE:LLY) products are sold in 120 countries around the world.

You can also take a look at 20 Countries That Produce the Most Oil In The World and 15 Best Pet Insurance Companies Heading into 2024.